Pharmacology

Action Mechanism of Action Reference
INHIBITOR Lymphocyte activation gene 3 protein inhibitor Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Melanoma 2 D008545 ClinicalTrials
Triple Negative Breast Neoplasms 2 D064726 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298009
FDA SRS OI8P0SFD4R